AngioDynamics Inc (ANGO) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry.
Over the past 4 years, AngioDynamics Inc has achieved a revenue compound annual growth rate (CAGR) of 0.1%, while earnings have grown at 1.9% CAGR.
Historical revenue and profitability trends for AngioDynamics Inc
The chart above illustrates AngioDynamics Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of AngioDynamics Inc's business.
How efficiently AngioDynamics Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue AngioDynamics Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project AngioDynamics Inc to continue focusing on sustainable operations. The consensus analyst rating is 4.6667 based on 3 analysts.
Based on our comprehensive analysis, AngioDynamics Inc (ANGO) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of AngioDynamics Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how AngioDynamics Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: ANGO Valuation, ANGO Dividend, ANGO Financial Health
Compare: ANGO vs AAPL, ANGO vs MSFT, ANGO vs GOOGL